Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 46.73 | 127.00 | 94.75 | 1.3404 | 1.6655 |
| MCF7 | Linsitinib | 1 | uM | 10 | 156.25 | 46.73 | 122.00 | 94.75 | 1.2876 | 1.5626 |
| MCF7 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 46.73 | 160.00 | 94.75 | 1.6887 | 2.3430 |
| MCF7 | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 46.73 | 172.00 | 94.75 | 1.8153 | 2.5887 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 46.73 | 55.00 | 94.75 | 0.5805 | 0.1733 |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 156.25 | 46.73 | 125.00 | 94.75 | 1.3193 | 1.6243 |
| MCF7 | Lapatinib | 1 | uM | 10 | 156.25 | 46.73 | 159.00 | 94.75 | 1.6781 | 2.3225 |
| MCF7 | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 46.73 | 139.00 | 94.75 | 1.4670 | 1.9122 |
| MCF7 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 178.00 | 94.75 | 1.8786 | 2.7114 |
| MCF7 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 88.00 | 94.75 | 0.9288 | 0.8602 |
| MCF7 | Erlotinib | 10 | uM | 10 | 156.25 | 46.73 | 155.00 | 94.75 | 1.6359 | 2.2406 |
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 46.73 | 267.00 | 94.75 | 2.8179 | 4.5233 |
| MCF7 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 46.73 | 85.00 | 94.75 | 0.8971 | 0.7980 |
| MCF7 | Lapatinib | 10 | uM | 10 | 156.25 | 46.73 | 56.00 | 94.75 | 0.5910 | 0.1942 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 80.00 | 94.75 | 0.8443 | 0.6942 | |
| MCF7 | 0 | uM | 10 | 312.50 | 95.00 | 226.00 | 242.50 | 0.9320 | 0.8984 | |
| MCF7 | Linsitinib | 0.01 | uM | 10 | 312.50 | 95.00 | 223.00 | 242.50 | 0.9196 | 0.8798 |
| MCF7 | Linsitinib | 0.031623 | uM | 10 | 312.50 | 95.00 | 250.00 | 242.50 | 1.0309 | 1.0456 |
| MCF7 | 0 | uM | 10 | 312.50 | 95.00 | 259.00 | 242.50 | 1.0680 | 1.0998 | |
| MCF7 | 17-AAG | 1 | uM | 10 | 312.50 | 95.00 | 79.00 | 242.50 | 0.3258 | -0.1275 |
| MCF7 | Linsitinib | 10 | uM | 10 | 312.50 | 95.00 | 193.00 | 242.50 | 0.7959 | 0.6892 |
| MCF7 | 17-AAG | 0.1 | uM | 10 | 312.50 | 95.00 | 73.00 | 242.50 | 0.3010 | -0.1770 |
| MCF7 | Lapatinib | 0.01 | uM | 10 | 312.50 | 95.00 | 309.00 | 242.50 | 1.2742 | 1.3926 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 312.50 | 95.00 | 178.00 | 242.50 | 0.7340 | 0.5911 |
| MCF7 | Lapatinib | 0.1 | uM | 10 | 312.50 | 95.00 | 323.00 | 242.50 | 1.3320 | 1.4724 |